Chief Scientific Officer of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), Roberts Christopher D., sells 2,500 shares worth $65,262
According to Black Diamond Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Mar 04 05:52 PM, company Chief Scientific Officer, Roberts Christopher D. disclosed selling 2,500 shares at a cost of $26.10. At the time of this transaction (Mar 03), this trade was worth $65,262 in total. As of Mar 03, Roberts Christopher D. now owns 3,200 shares in total worth about $75,936.0.
For the last few recent trades made by Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Chief Scientific Officer, Roberts Christopher D., we have the following information:
- SEC Form 4 filing: Nov 11: Sold 5,000 shares at the rate of $34.90 per share. Total worth of this trade was $174,500. Total number of shares owned as of Nov 11 were 0
Posted by
George Daniels
on Thursday March 04 2021, 7:50 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
